GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » YoY Rev. per Sh. Growth

Immunoclin (Immunoclin) YoY Rev. per Sh. Growth : 0.00% (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Immunoclin's YoY Rev. per Sh. Growth for the quarter that ended in Oct. 2014 was 0.00%.

Immunoclin's Revenue per Share for the three months ended in Oct. 2014 was $0.00.

Immunoclin YoY Rev. per Sh. Growth Historical Data

The historical data trend for Immunoclin's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin YoY Rev. per Sh. Growth Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
YoY Rev. per Sh. Growth
- - -100.00

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immunoclin YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Immunoclin's YoY Rev. per Sh. Growth for the fiscal year that ended in Jan. 2014 is calculated as:

YoY Rev. per Sh. Growth (A: Jan. 2014 )
=(Revenue per Share (A: Jan. 2014 )-Revenue per Share (A: Jan. 2013 ))/ | Revenue per Share (A: Jan. 2013 ) |
=(0-0.034)/ | 0.034 |
=-100.00 %

Immunoclin's YoY Rev. per Sh. Growth for the quarter that ended in Oct. 2014 is calculated as:

YoY Rev. per Sh. Growth (Q: Oct. 2014 )
=(Revenue per Share (Q: Oct. 2014 )-Revenue per Share (Q: Aug. 2013 )) / | Revenue per Share (Q: Aug. 2013 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunoclin YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Immunoclin's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
BOM:506128 ASX:ATX OSTO:ANNX IMUN ASX:FIJ ASX:FTT ATRX TSXV:THRM WAR:BLR FNAM ASX:NC6 XCNQ:VP ENLV ASX:RAC VODG TSXV:MFS OSTO:A1M XSAT:CLINE B ASX:MEB XCNQ:LILY
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Website
http://www.immunoclin.com
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines